Sean A. McCarthy - Mar 18, 2025 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
CEO, Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Sean A. McCarthy
Stock symbol
CTMX
Transactions as of
Mar 18, 2025
Transactions value $
-$22,556
Form type
4
Date filed
3/20/2025, 04:34 PM
Previous filing
Feb 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale -$22.6K -37.7K -3.65% $0.60 995K Mar 18, 2025 Direct F1, F2
holding CTMX Common Stock 93.2K Mar 18, 2025 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units ("RSUs").
F2 Includes 488,750 RSUs.
F3 Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.